Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates
Clinical trial NCT07703514 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07703514
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-07
- Primary completion
- 2027-04-12
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.